Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 301 - 330 of 356
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Procren Depot PDS 3.75 mg, 11.25 mg, 30 mg injektiokuiva-aine ja liuotin, suspensiota varten SPC 2024-08-15
		European Medicines Agency's website: Procysbi - EMA: EPAR PI Finnish Swedish
PL	Resepti	Produodopa 240 mg-ml + 12 mg-ml SPC 2023-11-17
PL	Resepti	Profast 10 mg-ml, 20 mg-ml injektio-infuusioneste, emulsio, SPC 2024-07-18
PL	Resepti	Progit 50 mg tabletti, kalvopäällysteinen SPC 2024-01-11
PL	Resepti	Prograf 0.5 mg, 1 mg ja 5 mg kapseli, kova SPC 2024-10-18
PL	Resepti	Prograf 5 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-10-18
PL	Resepti	Progynova 1 mg 2 mg tabletti SPC 2023-10-10
PL	Resepti	Progynova 1 mg 2 mg tabletti SPC 2023-10-10
PL	Resepti	Prohance 279,3 mg-ml injektioneste, liuos SPC 2024-08-26
PL	Resepti	Prohance 279,3 mg-ml injektioneste, liuos, esitäytetty ruisku SPC 2024-05-09
PL	Resepti	Prolastina 1000 mg infuusiokuiva-aine ja liuotin, liuosta varten SPC 2024-07-15
PL	Resepti	Prolastina 4000 mg, 5000 mg infuusiokuiva-aine ja liuotin, liuosta varten SPC 2023-11-15
		European Medicines Agency's website: Prolia - EMA: EPAR PI Finnish Swedish
PL	Resepti	Prolutex 25 mg injektioneste, liuos SPC 2023-11-17
PL	Resepti	Prolutex 25 mg injektioneste, liuos, esitäytetty ruisku SPC 2023-11-17.doc
		European Medicines Agency's website: Prometax - EMA: EPAR PI Finnish Swedish
PL	Resepti	Promictan 0.4 mg depottabletti SPC 2020-10-23
PL	Resepti	Pronaxen 25 mg - ml oraalisuspensio SPC 2022-10-19
PL	Resepti	Pronaxen 250 mg tabletti SPC 2022-10-24
PL	Itsehoito	Pronaxen 250 mg tabletti SPC 2022-10-24 OTC
PL	Resepti	Pronaxen 500 mg tabletti SPC 2022-10-24
PL	Resepti	Propecia 1 mg tabletti, kalvopäällysteinen SPC 2024-07-12
PL	Resepti	Propess 10 mg depotlääkevalmiste, emättimeen SPC 2021-09-10
PL	Resepti	Propofol-Lipuro 10 mg-ml injektio-infuusioneste, emulsio, SPC 2024-07-04
PL	Resepti	Propofol-Lipuro 20 mg-ml injektio-infuusioneste, emulsio, SPC 2024-07-04
PL	Resepti	Propofol-Lipuro 5 mg-ml injektioneste, emulsio SPC 2024-07-04
PL	Resepti	Propolipid 10 mg-ml, 20 mg-ml injektio-infuusioneste, emulsio SPC 2024-07-31
PL	Resepti	Propolipid 10 mg-ml, 20 mg-ml injektio-infuusioneste, emulsio, esitäytetty ruisku SPC 2024-07-31
PL	Resepti	Propral 10 mg, 40 mg tabletti SPC 2023-09-19
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >